News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Daily News Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US Yael L. Maxwell December 07, 2017
News Conference News AHA 2017 Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality Michael O'Riordan November 14, 2017
News Conference News AHA 2017 Better PCI Outcomes Not Guaranteed at Top-Ranked Hospitals Todd Neale November 12, 2017
News Daily News Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI Yael L. Maxwell October 20, 2017
News Daily News Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR Shelley Wood October 16, 2017
News Daily News What Works, What Matters? Patient-Centered Endpoints Gain Traction in CV Clinical Trials Caitlin E. Cox October 13, 2017
News Conference News PCR London Valves 2017 Valve Deterioration and Durability Definitions Now Standardized in New Guide Shelley Wood September 25, 2017
News Daily News Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease Yael L. Maxwell September 15, 2017
News Features A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease Yael L. Maxwell August 02, 2017
News Daily News Palliative Care Ups Quality of Life, Mental Health for HF Patients Caitlin E. Cox July 19, 2017
News Daily News No Downside to Medicare Penalties for Hospital Readmissions for HF, Acute MI Ashley Lyles July 18, 2017
News Conference News EuroPCR 2017 EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40 Shelley Wood May 12, 2017
News Daily News Cardiac Intensive Care Units Face an Ever More Complex Patient Population Caitlin E. Cox April 28, 2017
News Daily News Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes Michael O'Riordan April 27, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017